<DOC>
	<DOC>NCT00828906</DOC>
	<brief_summary>To evaluate the effectiveness of DuoTrav Eye Drops in gaining or maintaining control of target Intraocular Pressures (tIOP) in patients diagnosed with, and being treated for, open-angle glaucoma (OAG) or ocular hypertension (OH).</brief_summary>
	<brief_title>DuoTravÂ® Eye Drops As Replacement Therapy Program</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Cloprostenol</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<criteria>Patients with OAG or OH for whom single agent therapy provides insufficient intraocular pressure reduction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>IOP</keyword>
	<keyword>DuoTrav</keyword>
</DOC>